BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  Sangui BioTech International Inc.: Revenues Attain USD 133,000 in Financial Year 2014

  September 25, 2014

   · 

  1 min read
• Pharm Country

  PTC Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  September 25, 2014

   · 

  1 min read
• Regeneus (ASX:RGS) Receives R&D Tax Incentive Refund Of $3.7 Million

  September 25, 2014

   · 

  1 min read
• Drug Development

  Radiant Research/Clinical Research Advantage, Inc. Enrolls More Than 8,000 Subjects For Hepatitis B Vaccine Study

  September 25, 2014

   · 

  1 min read
• Antisense Therapeutics Limited Release: Placement And Share Purchase Plan

  September 25, 2014

   · 

  4 min read
• BioMidwest

  Electrical Geodesics, Inc. Release: $1.7 Million Extension Of SBIR Grant From National Institute of Mental Health

  September 25, 2014

   · 

  2 min read
• Business

  AP-HP, The Paris Public Hospitals Group, And Magnisense Sign A Partnership Agreement To Develop Emergency Diagnostic Tests For Cardiovascular Diseases

  September 25, 2014

   · 

  5 min read
• Galapagos NV Increases Share Capital Through Warrant Exercises

  September 25, 2014

   · 

  3 min read
• Genetown

  CluePoints Shortlisted For 2014 Scrip Awards

  September 25, 2014

   · 

  2 min read
• FDA

  AbbVie’s HUMIRA® (adalimumab) Receives U.S. FDA Approval For The Treatment Of Pediatric Patients With Moderately To Severely Active Crohn’s Disease

  September 25, 2014

   · 

  8 min read